not sure who the companies (Merck) are but the old strategy of anteobind only being used for eugeni have been shelved.
- Meaningful discussions with parties involved in the point of care development relating to a joint point-of-care (POC) assay development and validation work for the incorporation of AnteoBind were commenced.
- Development of assay and conjugation services offering, using AnteoBind activated particles was offered to commercial partners.
EuGeni, page-2666
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.001(2.27%) |
Mkt cap ! $55.53M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.2¢ | $3.094K | 138.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 183213 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 516112 | 4 |
View Market Depth
| Last trade - 15.08pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
0.001 ( 2.33 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 218423 | ||
| Last updated 15.04pm 13/06/2024 ? | |||||
| ADO (ASX) Chart |